SPOTLIGHT -
Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.
Electroconvulsive Therapy in Individuals with Behavioral and Psychological Symptoms of Dementia
What Will the Future of Alzheimer Disease Treatment Look Like?
FDA: Specific Fast Track Designation for Subcutaneous Formulation of Leqembi for Alzheimer Disease Needed for Rolling Review
Diagnosis and Treatment of Depressive and Memory Problems in Older Adults
From the Pages of Psychiatric Times: March 2024
The Week in Review: March 11-15